Despite how common GLP-1 use has become, there has been relatively little dermatology-focused research on their cutaneous side effects, with most of the existing literature limited to individual case reports. For the cross-sectional analysis, Fat and colleagues compared cutaneous adverse events reported in the FDA Adverse Event Reporting System (FAERS) for the GLP-1 receptor agonists semaglutide (Ozempic/ Wegovy, Novo Nordisk), liraglutide, exenatide and dulaglutide (Trulicity, Eli Lilly) with cutaneous adverse event reports for the dipeptidyl peptidase-4 (DPP-IV) inhibitors sitagliptin, saxagliptin, linagliptin and alogliptin
L-Arginine and L-Carnitine are amino acids that facilitate the production of energy from fat by the body, enhance blood flow, and promote erectile function
Patients frequently discover that their insurance plan offsets, or even entirely covers, the expenses of branded semaglutide, making this potent weight-loss option more accessible and affordable
Allulose was linked to better insulin sensitivity and improved endurance in animal studies